SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-18-015760
Filing Date
2018-03-20
Accepted
2018-03-20 10:50:35
Documents
1
Period of Report
2018-03-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv488977_4a.html 4/A  
1 OWNERSHIP DOCUMENT tv488977_4a.xml 4/A 4053
  Complete submission text file 0001144204-18-015760.txt   5788
Mailing Address 1745 BROADWAY, 17TH FLOOR NEW YORK NY 10019
Business Address 1745 BROADWAY, 17TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560
Business Address
Almenoff June Sherie (Reporting) CIK: 0001492647 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36641 | Film No.: 18701006